TrialAnnals of oncology : official journal of the European Society for Medical Oncology2014

Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients.

E A Mittendorf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.